NOW CLOSER THAN BEFORE
BostonSight SCLERAL & PROSE
Now in India
Manufactured @ LVPEI, India
The ‘LVPEI’ and ‘Boston Foundation for Sight’ collaboration started in 2017 intending to improve the access of specialized lenses to patients in underserved geographies. These lenses restore visual function, support healing, and reduce symptoms, avoid corneal transplantation in some cases and improve quality of life for patients. Will soon start catering to patients in South-East and Middle-East Asia.
State of art manufacturing facility- ISO 13485 Certified
The LVPEI BostonSight Lens Manufacturing Lab is ISO 13485 certified by the British Standards Institution (BSI). This accreditation is a testimony to the high-quality of LVPEI scleral lenses which are offered to other eye care practitioners also beyond LVPEI, for further dispensing to the patients in need.
About the lens
BostonSight PROSE (Prosthetic Replacement of the Ocular Surface Ecosystem) is a treatment
pioneered by BostonSight that restores visual function, supports healing, reduces symptoms and improves quality of life for patients suffering with complex corneal disease. pioneered by BostonSight that restores visual function, supports healing, reduces symptoms and improves the quality of life for patients suffering from complex corneal disease. BostonSight PROSE treatment uses FDA approved (1994) custom designed and fabricated prosthetic devices to replace or support impaired ocular surface system functions.
BostonSight PROSE treatment is available at top-ranked academic medical centres and clinics across India.
BostonSight SCLERAL is the first and only evidence-based lens design that has leveraged
patient fitting data and clinical experience – from 6 years of patient outcomes on more than 7,000 eyes. Designed to be easily integrated into today’s busy and sophisticated practices, BostonSight SCLERAL helps you achieve a smart, predictable, and efficient fit with optimal vision. Our commitment to ongoing data analysis ensures a smart fit for life.
BostonSight SCLERAL is an FDA-cleared lens design for the treatment of irregular corneas and ocular surface disease including dry eye.
Available with 40+ practitioners across India.
What experts have to say
Patient’s information & Resources
BostonSight SCLERAL is the first and only scleral lens that leverages six years of patient data of over 7,000 eyes to provide a data-driven scleral lens fitting system that optimizes fitting efficiency resulting in fewer office visits for you—the patient.
Am I a candidate for BostonSight SCLERAL?
BostonSight SCLERAL helps patients with many conditions:
IRREGULAR CORNEA / DISTORTED CORNEA
- Pellucid marginal degeneration
- Terrien’s marginal degeneration
- Salzmann’s nodular degeneration
- Corneal dystrophy
OCULAR SURFACE DISEASE
- Dry eye syndrome
- Ocular graft-versus-host disease (GVHD)
- Sjögren’s syndrome
- Stevens-Johnson syndrome
- Chemical or thermal burns
- Nerve damage
- Herpes simplex
- Corneal exposure
AFTER EYE SURGERY
- Cornea transplant
- Photorefractive keratectomy (PRK)
- Radial keratotomy (RK)
- For injury
- For scarring
- Corneal dystrophy
Only a licensed practitioner can prescribe and order BostonSight SCLERAL lenses. Ask your eye care professional if BostonSight SCLERAL is right for you.